JunD is involved in the antiproliferative effect of Δ9-tetrahydrocannabinol on human breast cancer cells (original) (raw)
Bakiri L, Matsuo K, Wisniewska M, Wagner EF, Yaniv M . (2002). Promoter specificity and biological activity of tethered AP-1 dimers. Mol Cell Biol22: 4952–4964. ArticleCAS Google Scholar
Berdyshev EV, Schmid PC, Krebsbach RJ, Hillard CJ, Huang C, Chen N et al. (2001). Cannabinoid-receptor-independent cell signalling by N-acylethanolamines. Biochem J360: 67–75. ArticleCAS Google Scholar
Blazquez C, Carracedo A, Barrado L, Real PJ, Fernandez-Luna JL, Velasco G et al. (2006). Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J20: 2633–2635. ArticleCAS Google Scholar
Caffarel MM, Sarrio D, Palacios J, Guzman M, Sanchez C . (2006). Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. Cancer Res66: 6615–6621. ArticleCAS Google Scholar
Carracedo A, Gironella M, Lorente M, Garcia S, Guzman M, Velasco G et al. (2006a). Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res66: 6748–6755. ArticleCAS Google Scholar
Carracedo A, Lorente M, Egia A, Blazquez C, Garcia S, Giroux V et al. (2006b). The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell9: 301–312. ArticleCAS Google Scholar
De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M et al. (1998). The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA95: 8375–8380. ArticleCAS Google Scholar
Drusco A, Zanesi N, Roldo C, Trapasso F, Farber JL, Fong LY et al. (2005). Knockout mice reveal a tumor suppressor function for Testin. Proc Natl Acad Sci USA102: 10947–10951. ArticleCAS Google Scholar
Eferl R, Wagner EF . (2003). AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer3: 859–868. ArticleCAS Google Scholar
Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D et al. (2004). JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell118: 781–794. ArticleCAS Google Scholar
Giuliano M, Calvaruso G, Pellerito O, Portanova P, Carlisi D, Vento R et al. (2006). Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway. Int J Mol Med17: 811–819. CASPubMed Google Scholar
Guzman M . (2003). Cannabinoids: potential anticancer agents. Nat Rev Cancer3: 745–755. ArticleCAS Google Scholar
Guzman M, Duarte MJ, Blazquez C, Ravina J, Rosa MC, Galve-Roperh I et al. (2006). A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer95: 197–203. ArticleCAS Google Scholar
Hampson AJ, Grimaldi M, Axelrod J, Wink D . (1998). Cannabidiol and (−)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA95: 8268–8273. ArticleCAS Google Scholar
Hampson AJ, Grimaldi M, Lolic M, Wink D, Rosenthal R, Axelrod J . (2000). Neuroprotective antioxidants from marijuana. Ann NY Acad Sci899: 274–282. ArticleCAS Google Scholar
Iuvone T, Esposito G, Esposito R, Santamaria R, Di Rosa M, Izzo AA . (2004). Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J Neurochem89: 134–141. ArticleCAS Google Scholar
Lallemand D, Spyrou G, Yaniv M, Pfarr CM . (1997). Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts. Oncogene14: 819–830. ArticleCAS Google Scholar
Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L et al. (2006). Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther318: 1375–1387. ArticleCAS Google Scholar
Maccarrone M, Di Rienzo M, Battista N, Gasperi V, Guerrieri P, Rossi A et al. (2003). The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem278: 33896–33903. ArticleCAS Google Scholar
Malumbres M, Barbacid M . (2001). To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer1: 222–231. ArticleCAS Google Scholar
Mechta F, Lallemand D, Pfarr CM, Yaniv M . (1997). Transformation by ras modifies AP1 composition and activity. Oncogene14: 837–847. ArticleCAS Google Scholar
Mechta-Grigoriou F, Gerald D, Yaniv M . (2001). The mammalian Jun proteins: redundancy and specificity. Oncogene20: 2378–2389. ArticleCAS Google Scholar
Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S, Yaniv M . (1994). Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell76: 747–760. ArticleCAS Google Scholar
Salazar M, Rojo AI, Velasco D, de Sagarra RM, Cuadrado A . (2006). Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem281: 14841–14851. ArticleCAS Google Scholar
Sarnataro D, Pisanti S, Santoro A, Gazzerro P, Malfitano AM, Laezza C et al. (2006). The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. Mol Pharmacol70: 1298–1306. ArticleCAS Google Scholar
Stickeler E, Kittrell F, Medina D, Berget SM . (1999). Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene18: 3574–3582. ArticleCAS Google Scholar
van Dam H, Duyndam M, Rottier R, Bosch A, de Vries-Smits L, Herrlich P et al. (1993). Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J12: 479–487. ArticleCAS Google Scholar
Weitzman JB, Fiette L, Matsuo K, Yaniv M . (2000). JunD protects cells from p53-dependent senescence and apoptosis. Mol Cell6: 1109–1119. ArticleCAS Google Scholar
Zhao Q, He Z, Chen N, Cho YY, Zhu F, Lu C et al. (2005). 2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells. J Biol Chem280: 26735–26742. ArticleCAS Google Scholar